Are Higher Body Mass Index and Worse Metabolic Parameters Associated with More Aggressive Differentiated Thyroid Cancer? A Retrospective Cohort Study.

PTC histological variants body mass index (BMI) differentiated thyroid cancer (DTC) metabolic syndrome obesity papillary thyroid carcinoma (PTC) triglycerides/high-density lipoprotein (HDL)–cholesterol ratio

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
02 Mar 2024
Historique:
received: 01 02 2024
revised: 17 02 2024
accepted: 29 02 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: epublish

Résumé

Obesity is a risk factor for differentiated thyroid cancer (DTC), but the association with DTC aggressiveness is controversial. To evaluate the association between preoperative body mass index (BMI)/other metabolic parameters and DTC aggressiveness in our surgical cohort, we retrospectively evaluated patients following thyroid surgery who were diagnosed with DTC between December 2013 and January 2021. Baseline characteristics, histopathological features, treatment modalities, and follow-up data were studied. We conducted logistic regression to analyze the association between BMI/other metabolic parameters and adverse DTC features. The final study cohort included 211 patients (79.6% women; mean age± standard deviation 48.7 ± 15.9 years): 66 (31.3%) with normal weight, 81 (38.4%) with overweight, and 64 (30.3%) with obesity. The median follow-up was 51 months (range 7-93). Complete versus partial thyroidectomy was more common among patients living with overweight or obesity than in normal weight patients (79.7% versus 61.7%,

Identifiants

pubmed: 38470692
pii: healthcare12050581
doi: 10.3390/healthcare12050581
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Yasmin Abu Arar (Y)

Internal Medicine Ward D, Soroka University Medical Center, Beer-Sheva 84101, Israel.

Michael Shilo (M)

Department of Epidemiology, Biostatistics and Community Health, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

Natalya Bilenko (N)

Department of Epidemiology, Biostatistics and Community Health, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

Michael Friger (M)

Department of Epidemiology, Biostatistics and Community Health, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

Hagit Marsha (H)

Faculty of Health Sciences, Goldman Medical School, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

David Fisher (D)

Endocrinology Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel.

Merav Fraenkel (M)

Endocrinology Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

Uri Yoel (U)

Endocrinology Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84015, Israel.

Classifications MeSH